Alfred Merriweather Net Worth & Insider Trades

Alfred Merriweather - Chief Financial Officer, Adamas Pharmaceuticals Inc

As of September 23, 2019

What is Alfred Merriweather's Net Worth?

The current estimated net worth of Adamas Pharmaceuticals Inc's Chief Financial Officer, Alfred Merriweather, is estimated to be about $49.73K . Alfred Merriweather owns about 48,019 units of Adamas Pharmaceuticals Inc common stock. In the last 2 years at Adamas Pharmaceuticals Inc, Alfred Merriweather has sold an estimated value of $49.73K worth.

What is Alfred Merriweather's Past Insider Trading?

Alfred Merriweather's largest sale order was 1,665 units , worth over $31.93K on September 21, 2018. In total, Alfred Merriweather has made about 6 transactions over 2 years of their time at Adamas Pharmaceuticals Inc. Alfred Merriweather usually trades in March and September, with the busiest year in 2019. The most recent transaction was a sale order of 1,584 units , worth over $10.95K on September 23, 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Adamas Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Stock Awards
Option Awards
Other Compensation
Total
Neil F. McFarlane 2020 $604,167 $31,300 $431,300 $199,000 $233,220 $193,954 $1,692,941
Neil F. McFarlane 2019 $182,292 - $125,200 $781,250 $957,325 $34,575 $2,080,642
Vijay Shreedhar, Ph.D. 2020 $418,034 $21,700 $224,600 $55,100 $64,367 $58,498 $842,299
Vijay Shreedhar, Ph.D. 2019 $252,344 - $130,200 $321,063 $397,513 $128,974 $1,230,094
Christopher B. Prentiss 2020 $386,667 $20,000 $184,000 $23,200 - $6,912 $620,779
Christopher B. Prentiss 2019 $358,333 - $184,000 $245,188 $298,980 $7,140 $1,093,641
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1328143/000132814321000033/adms2021proxystatement.htm

What are Adamas Pharmaceuticals Inc's Past Insider Trades?

Adamas Pharmaceuticals Inc's most recent insider trade came on June 23, 2021 by Vijay Shreedhar who sold 6,200 units worth $31.98K . In the last 7 years, insiders at Adamas Pharmaceuticals Inc have sold an estimated value of $27.45M and bought an estimated value of $19.72M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are William Ericson, Director,  Gregory Went, Chief Executive Officer,  and Ivan Lieberburg, Director .

Adamas Pharmaceuticals Inc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1